Gland Pharma Limited
GLAND
Κατάταξη σε μετοχές
#3304
Gland Pharma Limited, established in Hyderabad, India, in 1978, is a... Gland Pharma Limited, established in Hyderabad, India, in 1978, is a pharmaceutical company that specializes in the creation, production, and global distribution of generic injectable medications. Its product line features key active pharmaceutical ingredients such as heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, among others. The company's extensive therapeutic portfolio encompasses anti-infectives, anesthetics, anticoagulants, antimalarials, cardiovascular drugs, gastrointestinal treatments, pain management, hormones, fertility aids, anti-cancer agents, gynecological remedies, neurological and central nervous system medications, respiratory treatments, blood-related products, ophthalmological and otological solutions, orthopedics, hematinics, and various vitamins, minerals, and nutrients. Additionally, Gland Pharma provides contract development services. The company primarily operates on a business-to-business (B2B) model, distributing its products across major markets including the United States, Europe, Canada, Australia, India, and other international territories. Gland Pharma Limited functions as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
Τιμή μετοχής
$32.32
Κεφαλαιοποίηση
$5.33B
Αλλαγή (1 ημέρα)
-3.01%
Αλλαγή (1 έτος)
47.99%
Χώρα
IN
Εμπόριο Gland Pharma Limited (GLAND)
Κατηγορία
Healthcare
Δείκτης P/S για Gland Pharma Limited (GLAND)
Δείκτης P/S στις October 2026 TTM: 7.47
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή μετοχής της Gland Pharma Limited, ο τρέχων δείκτης P/S (TTM) είναι 7.47. Στο τέλος του 2024, ο δείκτης ήταν 5.27.
Ιστορικό P/S για την Gland Pharma Limited από 2017 έως 2026
Δείκτης P/S στο τέλος κάθε έτους
| Έτος | P/S Ratio | Αλλαγή |
|---|---|---|
| 2026 (TTM) | 7.47 | 63.72% |
| 2025 | 4.56 | -13.61% |
| 2024 | 5.27 | -9.26% |
| 2023 | 5.81 | -52.56% |
| 2022 | 12.25 | 7.08% |
| 2021 | 11.44 | 4.38% |
| 2020 | 10.96 | -26.45% |
| 2019 | 14.91 | -20.73% |
| 2018 | 18.80 | -1.35% |
| 2017 | 19.06 | 0.00% |
Δείκτης P/S για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | P/S Ratio | Διαφορά P/S Ratio | Χώρα |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | -5.46% |
IN
|
